Objective-To ascertain attitudes to different methods of obtaining informed consent for randomised clinical trials (RCTs). Design Structured interviews with members of the public, medical secretaries and medical students. Setting The public were approached in a variety of public places. Medical secretaries and students were approached in their place of work. Subjects-Fifty members of the public, 25 secretaries and 25 students. Main outcome measures Views on RCTs were elicited, with particular emphasis on how subjects thought the concept of randomisation should be explained. Each participant was presented with descriptions ofproposed clinical trials and asked to select his or her preference from a range of options. Results-Written information was preferred over verbal information in 91 % of replies. Most respondents (860o) would prefer to sign a consent form. Of the seven statements explaining randomisation, a significant difference was found in favour ofexplanations that were less explicit about the play of chance (ANOVA; p=0 0004). Eighty-three per cent of participants thought that randomised trials were morally acceptable when there was no prior medical preference between treatments. However, over half (55%) thought they would find it upsetting to be offered entry in such a trial and a quarter thought the outcome of treatment might be adversely affected. Conclusions Our results offer some support for the idea that "economy with truth" is less unsettling than a frank description of the stark reality of what randomisation means. It is a matter of debate as to whether, if we are correct, autonomy should have precedence over beneficence.
Introduction
Randomised Clinical Trials (RCTs) are being carried out at an increasing rate, involving ever greater numbers of participants. They are accepted as the most reliable form of clinical research for detecting moderate differential effects of alternative treatments.' It is also widely accepted that consent for randomisation should be obtained in the majority of instances -certainly, most Research Ethics Committees (RECs) demand this. The process of obtaining consent for randomisation may affect a patient's experience of care, especially when treatment can be a matter of life and death. We were particularly concerned to find a form of words to describe the process of randomisation itself, since this has not previously been researched (see Discussion) and because it is a topic of great practical importance. Re-submissions to RECs are often required to improve on wording. The views of potential participants in trials should be taken into account. We were also concerned to find out how people think the offer of participating in a trial might affect them. The extra staff time and attention, and the deeper insight the patients might get into their care process, along with a feeling of altruism, might enhance experiences for patients. Against this, the feeling that the staff are not in control, resulting from the implied ignorance on a point of care, might be profoundly worrying. We therefore interviewed members of the public and people with medical knowledge (secretaries and students) to ascertain their views on how information should be presented to those considering participation in RCTs of different kinds and on the effect the offer to take part may have.
Method
Members of the general public (n=50) were interviewed in a variety of places in Leeds. They were approached in parks and outside shopping centres, in art galleries and libraries. Medical secretaries (n=25) were interviewed in their place of work and medical students (n= 25) approached outside the entrance to the library of Leeds University Medical School.
The interview was split into three sections, dealing with (i) methods for obtaining consent, (ii) explaining the concept of randomisation and (iii) the likely effect of being offered entry in a trial.
SECTION 1: VERBAL V WRITTEN CONSENT
Each person was asked to imagine himself first to be the sufferer from a non-life threatening but painful condition (migraine headaches -scenario 1) and then in a life-threatening situation (either parent of an unborn baby who is failing to grow properlyscenario 2; or a life-threatening form of cancerscenario 3). In each case the respondent was invited to read a description of his condition (appendix) and then to imagine that the doctors were unable to decide between two different methods of treatment. The rationale for the RCT was explained and he was then asked to imagine that he was to be invited to participate in such a study. Whether scenario 2 or 3 was described was determined by choosing one of two unmarked and shuffled opaque envelopes.
We first enquired about the preferred format for the relevant information. Possible answers were:
a -"Discussed in depth on a personal basis with your doctor, without any written information". b -"Discussed in depth on a personal basis with your doctor, and then be given a written copy of the information about the trial". c -"Given as a written copy to be read in your own time, and then discussed in depth on a personal basis with your doctor".
If he indicated that he would prefer to have written information, then he was asked to choose between two levels of detail, and he was asked if he wanted to sign a consent form. SECTION 
2: WORDING TO EXPLAIN RANDOMISATION
Seven statements (figure 1) were presented in a random order, and interviewees were asked to place a cross along a 100 mm visual-analogue scale corresponding to how good an explanation they thought each was. Respondents were asked whether they thought that clinical trials such as those described in section 1 were acceptable and whether they thought that being offered entry in a trial would be upsetting. In addition, they were asked whether they thought that being involved in a clinical trial would affect the outcome of their recovery and, if so, whether they thought that it would be for the better or for the worse.
The questionnaire was checked for readability by the "Word for Windows" Microsoft package and scored 11-6 on the Gunning Fog Index -a figure considered acceptable for patient information leaflets.2 The data were then analysed using SPCC for Windows, version 6 on an Elonex 486. The great majority of respondents preferred written information (90-8%) but opinion was nearly evenly Different descriptions of the seven(a-g) statements explaining the concept of randomisation A Once you have agreed to enter the trial, a computer will randomly allocate you to one of two possible methods of treatment.
Results
B Once you have agreed to enter the trial, a computer will perform the equivalent of tossing a coin to allocate you to one of two methods of treatnment.
C Once you have agreed to enter the trial, you will be randomly allocated to one of two possible methods of treatment by chance alone; that is, independent ofwho you are and who your doctor is. D Once you have agreed to enter the trial, a computer will perform the equivalent of drawing names otut of a hat to decide which of two methods of treatment to allocate you to.
E Once you have agreed to enter the trial, a computer and not a doctor will decide which of the two treatments to give you. Its decision will be random and due to chance alone, and not based upon the patient's or the doctor's decision.
F Once you have agreed to enter the trial, you will be allocated to one of two treatments with equal chances of each treatment being the one you will receive. G Once you have agreed to enter the trial, one of two methods of treatment will be chosen by chance, and not by a decision made by the patient or the doctor. The mean visual-analogue scores allotted on the seven different statements explaining randomisation ("a" to "g") in question 1 are shown in figure 1. Overall statement "f' ("... you will be allocated to one of two treatments, with each treatment having equal chance of being the one you will receive") was the most popular (mean score of 56&7 mm), while "b" (which involved the tossing of a coin) and "d" (which involved names pulled from a hat) were the least popular (mean scores 35-6 mm and 37-1 mm respectively (figure 1)). Differences in responses between the different groups of participants were sought using ANOVA, with the exception of statements "b" and "e", where the data were not normally distributed, and where the Kruskal Wallis test was used. The most striking difference (ANOVA; P=0 0004) applied to statement "g" ("... one of the two methods of treatment will be chosen by chance, and not by a decision made by the patient or doctor"), which was especially disliked by the public (Tukey -B test; P<0 05). The only other significant difference (Kruskal Wallis: P=0-026) was on statement "b" ("... a computer will perform the equivalent of tossing a coin to allocate you to one of two methods of treatment"), which was much less disliked by the medical students (Mann-Whitney; P=0 0095).
SECTION 3: EXPECTED EFFECTS OF BEING OFFERED ENTRY IN A TRIAL
Randomised clinical trials were considered ethically acceptable by 83% of respondents, given that there was no medical preference between treatments (equipoise).' In the individual groups, this corresponded to 82% of the general public; 88% of the medical secretaries, and 80% of medical students (p=07).
Over half of those questioned thought that they would find being invited to enter a clinical trial upsetting (55%), with figures for the general public, medical secretaries and medical students of 50%, 64% and 56% respectively (P=0-5). However, a smaller proportion (one third) thought that participating in an RCT would affect their recovery. Of those who thought that it would affect their recovery, 63-6% thought it would be for the worse (for example, "make me more likely to give up"), and 36A4% thought it would affect them for the better (for example, "make me try harder"). There was no measured difference across groups for any of these comparisons.
Discussion
The sample in our study was not perfect. Since the respondents were approached in public places they are unlikely to be completely "representative" of all citizens. An It is important, at least from the scientific and utilitarian perspectives, that a large proportion of citizens are prepared to take part in trials. Information offered to the participants must be of sufficient quality and quantity to obtain as near to genuine informed consent as is possible, yet ethics committees lack general rules for the wording construction of consent forms.
The question of exactly how detailed the written information should be remains to be answered. White et al7 conducted a study of whether breast cancer patients preferred long, medium, or short information leaflets to explain a chemotherapy trial. Like us, they found that a majority (68%) of patients preferred the more detailed option. In contrast to Simes,4 they did not demonstrate higher stress levels when more detail was provided. No study has yet defined the upper ceiling for the amount of detail which should be included. Too little information may conceal material which could affect decisions,8 while too much may obscure the crucial points or discourage careful reading.9 Clearly, there is no "perfect solution" which will match everyone's preference,'0 but it is interesting to note that when people are heavily involved in deciding on trial entry, non-participation rates are high." We also note that it is impossible for a person to make a rational judgment on how much information he would like until he has seen the information. Detailed leaflets, in which the crucial points are highlighted, might be the best compromise.
Patients can only make an informed choice if they fully understand the concept of randomisation.12
Even when patients are given an apparently explicit explanation of randomisation, many still fail to understand -in the study by Simes,4 over half the participants failed to grasp this concept. We believe we are the first authors specifically to explore the preferred wording to explain the concept of randomisation. The last author is carrying out a systematic review of the ethics literature relating to clinical trials and has ascertained that 83 articles contain empirical data. No other author has addressed this issue of the precise wording to be used to explain the concept of randomisation. Of seven statements in this study, two ("b" and "d") were clearly disliked by most of the people interviewed. Both of them explain change in terms of either "drawing names out of a hat", or "tossing a coin". The clear favourite explanation was "f ", which made no attempt to explain how chance would result in treatment allocation. Biofeedback involves learning relaxation techniques to decrease the size of muscle contractions in the forehead and seems to be effective. Recent research seems to suggest that it may work as well as, if not better than, drug treatment in decreasing the discomfort and number of migraine attacks.
Traditional drug therapy has been shown to decrease the symptoms of migraine, but does not prevent future attacks (which biofeedback may do).
Scenario 2 Please try and imagine yourself in the following situation for a few minutes. You are shortly to become a parent, but your unborn baby, which is not yet fully mature, is failing to grow properly.
There are two options to take in helping the baby, and the doctors are unsure in this case which option to take in the baby's best interest. They have invited you to enter into a trial.
In this trial, either the baby will be left in the womb and its progress monitored, or it will be delivered without delay, but both have possible problems.
Delivering the baby without delay means that it will be born prematurely and without fully developed breathing ability and will be at risk from infections. Leaving the baby inside the womb could also be dangerous, because the baby may not get enough blood supply to remain healthy.
Scenario 3
Please try and imagine yourself in the following situation for a few minutes. You have been diagnosed by your doctors as suffering from a life-threatening form of cancer.
In this trial, you will either receive drug treatment or surgery. If you are given drug treatment you will feel very sick for a few days and possibly lose some of your hair. Surgery to remove the cancerous tissue will leave a wound which will be sore, open to infection and leave a scar. In addition, surgery also runs a slight risk of death.
Because the doctors are uncertain about which method would be more effective in this case, they offer you entry into a trial.
